Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Wanshili Silk Sciences & Techniques is a specialized division of the Wensli Group focused on the intersection of traditional silk production and modern biotechnology. The company leverages advanced silk fibroin extraction and purification technologies to develop high-value applications in the medical and cosmetic sectors. Their product portfolio includes silk-based medical dressings, artificial skin substitutes, and bioactive skincare ingredients designed for wound healing and tissue regeneration. By transforming silk from a textile fiber into a biocompatible material, the company serves as a bridge between industrial manufacturing and life science innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Wanshili Silk Sciences & Techniques.